Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(G)

Scheme Returns

-0.31%

Category Returns

-0.26%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(G) -0.41 -0.74 -0.31 -1.28 2.88 21.93 14.27 17.63 20.15
Equity - Sectoral Fund - Pharma & Health Care -0.56 -0.26 -0.26 1.37 8.47 21.43 17.17 23.30 17.06

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    451,077.39

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    515.3218

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    301, Centrium, 3rd Floor, 57, L.B.S. Road Nav Pada, Kurla (West) Mumbai - 400070

  • Phone

    022 - 4617 0911

  • Fax

  • Email

    investorsupport.mfs@kfintech.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 99.66
Others : 0.34

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 105776.09 12.67
Divi's Laboratories Limited 67382.09 8.07
Lupin Limited 60554.16 7.26
Cipla Limited 52471.25 6.29
Apollo Hospitals Enterprise Limited 49833.94 5.97
Dr. Reddy's Laboratories Limited 46898.9 5.62
Vijaya Diagnostic Centre Limited 28539.2 3.42
MedPlus Health Services Limited 27670.68 3.32
Gland Pharma Limited 25472.07 3.05
GlaxoSmithKline Pharmaceuticals Limited 23913.74 2.87
Ajanta Pharma Limited 23650.19 2.83
Sai Life Sciences Limited 23466.85 2.81
Thyrocare Technologies Limited 21639.87 2.59
Abbott India Limited 19912.9 2.39
Aurobindo Pharma Limited 19391.25 2.32
Dr. Lal Path Labs Limited 19098.71 2.29
Mankind Pharma Limited 18058.7 2.16
Alkem Laboratories Limited 17823.33 2.14
Biocon Limited 17560.79 2.1
JB Chemicals & Pharmaceuticals Limited 16817.1 2.01
Pfizer Limited 16577.59 1.99
Narayana Hrudayalaya Limited 16236.81 1.95
IPCA Laboratories Limited 12519.26 1.5
Suraksha Diagnostic Limited 12388.44 1.48
Fortis Healthcare Limited 11293.34 1.35
Sanofi India Limited 11008.38 1.32
Sanofi Consumer Healthcare India Limited 10346.65 1.24
Max Healthcare Institute Limited 10230.8 1.23
Syngene International Limited 8324.48 1
Anthem Biosciences Limited 7516.43 0.9
Akums Drugs and Pharmaceuticals Limited 6981.58 0.84
Emcure Pharmaceuticals Limited 6202.42 0.74
AstraZeneca Pharma India Limited 5978.37 0.72
Indoco Remedies Limited 5122.19 0.61
Triparty Repo 3919.62 0.47
Orchid Pharma Limited 3578.68 0.43
Concord Biotech Limited 1613.27 0.19
Cash Margin - CCIL 26.08 0
Net Current Assets -1147.03 -0.14

Sectors - Holding Percentage

Sector hold percentage
Healthcare 95.35%
Retailing 3.32%
Business Services 1%
Miscellaneous 0.47%

Divident Details

Scheme Name Date Dividend (%)
No Data Found

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 102.69 -1.47 -0.97 8.57 9.5 0
HDFC Pharma and Healthcare Fund - Growth Option 506.59 -0.24 -0.15 6.96 8.85 0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 2552.23 -1.06 -0.5 4.96 7.64 27.8
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 7.7 -2.3 -1.54 2.63 3.92 24.3
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 512.42 -1.44 -1.83 3.54 3.91 22.29
Mirae Asset Healthcare Fund -Regular Growth 1583.14 -2.47 -1.38 3.51 3.8 20.93
UTI Healthcare Fund - Regular Plan - Growth Option 5.42 -2.15 -2.84 4.68 3.2 24.17
Nippon India Pharma Fund-Growth Plan-Growth 4510.77 -0.31 -1.28 2.55 2.88 21.93
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 453.42 -1.34 -2.49 3.41 2.28 21.35
LIC MF Healthcare Fund-Regular Plan-Growth 51.46 -1.7 -0.37 5.48 1.87 20.33

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 68969.15 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 66601.8 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 66136.11 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 65922 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 64821.04 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 63006.73 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 62259.56 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 61973.76 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 61646.36 -1.05 -0.75 2.75 0.21 22.08
Nippon India Small Cap Fund - Growth Plan - Growth Option 61027.03 -1.05 -0.75 2.75 0.21 22.08